A drug development crossroad lies ahead

Transcription

1 G L O B A L C B O C O S T E F F E C T I V E B I O A N A L Y T I C A L H I G H Q U A L I T Y E A R L Y S T A G E C L I N I C A L T R A N S L A T I O N A L M E D I C I N E H I G H L Y C O M P E T E N T A C C E S S I B L E T R U S T I N G A drug development crossroad lies ahead In today s complicated world of pharmaceutical product development it is not always easy to find the right way. Many different routes may lead to your final destination. But are they all equally direct? Probably not, and that is where QPS comes in. No matter how far along your product is in its development, our professionals will steer you along the right path.

2 Find out how to achieve your next development milestone ahead of schedule Find out how you can benefit from working with an extremely competent, high-quality, yet cost effective and accessible global CRO that will go aboveand-beyond to build a trusting relationship with you. G L O B A L C B O P R E C L I N I C A L D I S C O V E R Y C L I N I C A L D R U G D E V E L O P M E N T Q U A L I T Y S E R V I C E S B I O T E C H N O L O G Y P H A R M A C E U T I C A L

3 Join the many pharmaceutical and biotech companies that count on QPS global team of >750 qualified and experienced professionals to speed up drug discovery and development programs in the following six key R&D areas: Thank you for the report and stability data. I will discuss the next steps for this with CC. May I take a chance to thank you (and your colleagues) for all your hard work over the last few months; I have been really pleased with the way you came through against the tight timelines. Carl W. Biomarker Assay Specialist (Clinical Assay Group) DMPK QPS offers you immediate access to a team of senior scientists with decades of pharmaceutical and biotech drug discovery and development experience. We walk you through the appropriate ADME studies across a broad range of compound structures and therapeutic targets. For many, especially virtual, small and mid-size pharmaceutical firms, outsourcing ADME studies to an experienced CRO such as QPS is a practical alternative to building or expanding in-house DMPK departments. Expanded expertise and improved cost-effectiveness are among the many compelling advantages of outsourcing to QPS. Toxicology QPS offers you comprehensive preclinical packages to support your IND and NDA regulatory submissions with high-quality toxicology data. Over the past two decades, we have performed over a thousand GLP studies for local and international pharmaceutical and biotechnology companies, covering many different disease therapies. This vast experience is a testament to our ability to effectively deliver high quality toxicology data to you, our valued customers. Why not take advantage of QPS depth and breadth of experience in providing GLP-compliant services at our preclinical site in Asia? Bioanalysis QPS offers you one of the world s largest capacities in bioanalysis for small molecules and biologics, with bioanalytical facilities in the USA, Europe, India and Taiwan. Find out how a strategic outsourcing alliance with QPS can provide you with world class operational and service excellence in bioanalysis and help save valuable time and money. Translational Medicine QPS offers you specialized biomarker assay capabilities in various therapeutic niche areas, which enable you to follow targeted therapies and personalized medicines. For instance, in Alzheimer s studies, QPS can help you - given the right selection and evaluation of biomarkers in early drug development - to minimize the time required to reach critical decision points on items such as proof of concept (POC), dosing, candidate selection, and development risks.

4 S C I E N T I F I C E X P E R T I C E R E S P E C T N A L Y T I C A L V O L U N T E E R W U R K D E V E L O P M E D I C N E S P L O Y E E S B E N E F I T P A T I E N T S B E N E F I C I A L P A R T N E R S H I P S P H Early Stage Clinical QPS offers you 400 phase I beds on three continents - 24 in the Netherlands, 40 in Taiwan, 92 in India and 240 in the USA. This is one of the world s largest phase 1 site offerings of any CRO. For the past 15 years, QPS phase I sites have collectively completed more than a thousand clinical trials involving tens of thousands of study volunteers. We have studied every conceivable kind of molecular entity, large or small, either being investigated as part of a complex, first-in-man program or a single, large bioequivalence study. QPS possesses the clinical pharmacology experience that is critical for speeding up your early clinical development process. Late Stage Clinical QPS offers you clinical research operations in the US, Netherlands, India, and Taiwan. Expand your global reach through QPS and contain your clinical development costs by making use of QPS world wide contract clinical staffing and pharmacometrics (including data management, biostatistics, PK/PD evaluation and medical writing) capabilities. Our Vision We partner with our clients to discover and develop medicines that will benefit patients worldwide, and we foster strong ties to our communities through charitable contributions and volunteer work. QPS promotes a work-life balance by providing a fair, safe, ethical, familyfriendly, respectful and caring work environment. Because of this, we attract and retain dedicated and motivated employees through career growth opportunities, recognition for their contributions, and financial rewards. We seek mutually beneficial partnerships through an integrative approach to best serve our stakeholders and keep the stakeholders needs in focus while cultivating trust and mutual respect for our partners.

5 QPS is a reputable and profitable provider of world-class pharmaceutical development services, possessing unparalleled scientific expertise within our core competencies. From left to Right: Level 1: Jerry Gromelski, Irma Scheepstra, Level 2: Jeff Moran, Edwin van Vulpen, Livia Legg, Andrew Nehls, Lily Rosa, Jelle Hempenius, Marina Abanto, Mary Ann Gagnon, Brendon Bourg, Level 3: Jim Cunningham, Wendy Nelson Time is of the essence, so contact a member of the QPS Business Development Team today and find out what QPS can do for you North America Asia Europe DMPK, Bionalysis & Translational Medicine - Northeast: Wendy Nelson wendy.nelson@qps-usa.com - Mid Atlantic: Jerry Gromelski jerry.gromelski@qps-usa.com - Southeast: Marina Abanto marina.abanto@qps-usa.com - Central: Jim Cunningham jim.cunningham@qps-usa.com - West Coast: Jeff Moran jeff.moran@qps-usa.com Early & Late Stage Clinical - Andrew Nehls andrew.nehls@qps-usa.com - Central: Jim Cunningham jim.cunningham@qps-usa.com - West Coast: Jeff Moran jeff.moran@qps-usa.com Toxicology - Dave Dehler dave.dehler@qps-usa.com - Alex Chang (Taiwan) alex.chang@qps-taiwan.com.tw - Manish Kalwani (India) manish@bioserve.co.in - Alex Chang (Japan) alex.chang@qps-taiwan.com.tw - Alex Chang (Other Asian Countries) alex.chang@qps-taiwan.com.tw HQ BD Office DMPK, Toxicology, Bionalysis & Translational Medicine - Jelle Hempenius jelle.hempenius@qps.com Late Stage Clinical - Irma Scheepstra irma.scheepstra@qps.com Early Stage Clinical - Edwin van Vulpen edwin.van.vulpen@qps.com - Lily Rosa (USA) info@qps-usa.com

6 Call to arrange for a tour at one of QPS worldwide locations today NETHERLANDS USA TAIWAN INDIA QPS Taiwan QPS CTPS QPS Qualitix QPS Bio-Kinetic QPS HQ QPS Netherlands QPS Bioserve